Osteoporosis in Parkinson's disease
- PMID: 19346153
- DOI: 10.1016/j.parkreldis.2009.02.009
Osteoporosis in Parkinson's disease
Abstract
Patients affected by Parkinson's disease are at a high risk for fractures, mainly of the hip. These fractures are caused by falls due to postural imbalance, neurological impairment and reduced bone mass. The purpose of this study was (1) to investigate the correlations and the pathophysiological mechanisms underlying bone loss in Parkinson's disease and appraise bone loss or fracture risk reduction interventions; (2) to develop a research agenda that informs the design and development of risk reduction strategies. Osteoporosis and osteopenia are very common findings in patients with Parkinson's disease, affecting up to 91% of women and 61% of men. Reduced bone mass in Parkinsonian patients seems to be caused mainly by reduced mobility through a mechanism similar to that observed in other neurological diseases. Endocrine (such as vitamin D deficiency), nutritional and iatrogenic factors also play an important role in bone mass depletion. Female gender, disease duration and severity (Hoehn and Yahr stages III and IV), old age and low body mass index are related to more severe osteoporosis. Vitamin D supplementation and bisphosphonates seem to be effective in reducing the risk of nonvertebral fractures in patients affected by Parkinson's disease. Prevention and evaluation of osteoporosis through bone mass density assessment should be considered in all patients with Parkinson's disease.
Similar articles
-
Parkinson's disease and osteoporosis.Age Ageing. 2013 Mar;42(2):156-62. doi: 10.1093/ageing/afs161. Epub 2012 Nov 6. Age Ageing. 2013. PMID: 23132148 Review.
-
Bone and mineral metabolism in older adults with Parkinson's disease.Age Ageing. 2009 Nov;38(6):675-80. doi: 10.1093/ageing/afp137. Epub 2009 Aug 15. Age Ageing. 2009. PMID: 19684354
-
[Bone changes in Parkinson's disease].No To Shinkei. 1993 Aug;45(8):719-24. No To Shinkei. 1993. PMID: 8217395 Japanese.
-
Review article: Osteoporosis and inflammatory bowel disease.Aliment Pharmacol Ther. 2004 May 1;19(9):941-52. doi: 10.1111/j.1365-2036.2004.01876.x. Aliment Pharmacol Ther. 2004. PMID: 15113361 Review.
-
Can early onset bone loss be effectively managed in post-stroke patients? An integrative review of the evidence.Age Ageing. 2008 Mar;37(2):142-50. doi: 10.1093/ageing/afm198. Age Ageing. 2008. PMID: 18349011 Review.
Cited by
-
Prognostic Factors of Hip Fracture in Elderly: A Systematic Review.Int J Prev Med. 2024 Aug 30;15:42. doi: 10.4103/ijpvm.ijpvm_169_23. eCollection 2024. Int J Prev Med. 2024. PMID: 39381356 Free PMC article. Review.
-
Bone involvement in the early stages of Parkinson's disease: a case-control study.J Int Med Res. 2024 Mar;52(3):3000605241237880. doi: 10.1177/03000605241237880. J Int Med Res. 2024. PMID: 38518193 Free PMC article.
-
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel.J Parkinsons Dis. 2024;14(1):53-63. doi: 10.3233/JPD-230168. J Parkinsons Dis. 2024. PMID: 38217610 Free PMC article. Review.
-
Do Bone Mineral Density, Trabecular Bone Score, and Hip Structural Analysis Differ in Indian Men with Parkinson's Disease? A Case-Control Pilot Study from a Tertiary Center in Southern India.Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):496-501. doi: 10.4103/aian.aian_29_23. Epub 2023 Jul 20. Ann Indian Acad Neurol. 2023. PMID: 37970318 Free PMC article.
-
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests.Front Neurol. 2023 May 25;14:1174698. doi: 10.3389/fneur.2023.1174698. eCollection 2023. Front Neurol. 2023. PMID: 37305739 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
